CALL/AMGEN/500/0.1/17.01.25 Share Price

Warrant

DE000GG1SV27

Market Closed - BOERSE MUENCHEN 19:27:11 17/05/2024 BST
0.108 EUR -9.24% Intraday chart for CALL/AMGEN/500/0.1/17.01.25
Current month+163.41%
1 month+145.45%
Date Price Change
17/05/24 0.108 -9.24%
16/05/24 0.119 +6.25%
15/05/24 0.112 +15.46%
14/05/24 0.097 +7.78%
13/05/24 0.09 -27.42%

Real-time BOERSE MUENCHEN

Last update May 17, 2024 at 07:27 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying AMGEN INC.
Issuer Goldman Sachs
WKN GG1SV2
ISINDE000GG1SV27
Date issued 03/01/2024
Strike 500 $
Maturity 17/01/2025 (245 Days)
Parity 10 : 1
Emission price 0.07
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.145
Lowest since issue 0.029
Delta0.05x
Omega 10.12
Premium60.54x
Gearing191.63x
Moneyness 0.6249
Difference Strike 187.5 $
Difference Strike %+37.51%
Spread 0.1
Spread %50.00%
Theoretical value 0.1530
Implied Volatility 31.47 %
Total Loss Probability 96.87 %
Intrinsic value 0.000000
Present value 0.1530
Break even 501.66 €
Theta-0.01x
Vega0.03x
Rho0.01x

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.
Sector
-
More about the company

Ratings for Amgen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Amgen Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5 USD
Average target price
314.1 USD
Spread / Average Target
+0.51%
Consensus